Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats

Abstract

The findings provide novel evidence of a causative role of increased DNA methylation in programming of heart hypertrophy and reduced cardiac contractility, and suggest potential therapeutic targets of demethylation in the treatment of failing heart and ischaemic heart disease.